{"title":"如果你还没听说过……","authors":"","doi":"10.1002/adaw.34595","DOIUrl":null,"url":null,"abstract":"<p>Robert F. Kennedy Jr., Secretary of the federal Department of Health and Human Services, is supporting the use of psychedelic drugs to treat depression, trauma, and other conditions. “This line of therapeutics has tremendous advantage if given in a clinical setting and we are working very hard to make sure that happens within 12 months,” Kennedy told Congress recently. Even supporters of these drugs were surprised. But the commercial attraction is there. This could make for an odd friendship between legalization groups like the Drug Policy Alliance and the Trump Administration.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 28","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In Case You Haven't Heard…\",\"authors\":\"\",\"doi\":\"10.1002/adaw.34595\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Robert F. Kennedy Jr., Secretary of the federal Department of Health and Human Services, is supporting the use of psychedelic drugs to treat depression, trauma, and other conditions. “This line of therapeutics has tremendous advantage if given in a clinical setting and we are working very hard to make sure that happens within 12 months,” Kennedy told Congress recently. Even supporters of these drugs were surprised. But the commercial attraction is there. This could make for an odd friendship between legalization groups like the Drug Policy Alliance and the Trump Administration.</p>\",\"PeriodicalId\":100073,\"journal\":{\"name\":\"Alcoholism & Drug Abuse Weekly\",\"volume\":\"37 28\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alcoholism & Drug Abuse Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34595\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34595","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
联邦卫生与公共服务部部长小罗伯特·f·肯尼迪（Robert F. Kennedy Jr.）支持使用致幻剂来治疗抑郁症、创伤和其他疾病。肯尼迪最近告诉国会：“如果在临床环境中给予这种治疗方法，将具有巨大的优势，我们正在努力确保在12个月内实现这一目标。”甚至这些药物的支持者也感到惊讶。但商业吸引力是存在的。这可能会使毒品政策联盟（Drug Policy Alliance）等合法化组织与特朗普政府之间形成一种奇怪的友谊。
Robert F. Kennedy Jr., Secretary of the federal Department of Health and Human Services, is supporting the use of psychedelic drugs to treat depression, trauma, and other conditions. “This line of therapeutics has tremendous advantage if given in a clinical setting and we are working very hard to make sure that happens within 12 months,” Kennedy told Congress recently. Even supporters of these drugs were surprised. But the commercial attraction is there. This could make for an odd friendship between legalization groups like the Drug Policy Alliance and the Trump Administration.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
